MedPath

Lung Function and Inflammatory Markers in Cement Dust Exposed Workers: A Cross-shifts Study

Completed
Conditions
Airway Obstruction
Registration Number
NCT00727714
Lead Sponsor
Sykehuset Telemark
Brief Summary

The aim of the study is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours).

Detailed Description

OBJECTIVE:

Cement dust is suspected to be one of the main factors causing increased mortality among workers not only in the cement production industry, but also in the construction industry worldwide. Our aim is to examine possible changes in lung function, nitric oxide levels and systemic inflammatory markers in cement dust exposed workers, during one shift (6-8 hours).

METHODS:

All employees from Norwegian cement plants, are invited to participate. The workers will perform spirometry, single-breath determination of carbon monoxide uptake, blood samples before and after a working shift of 6-8 hours, and again after 24 hours. Information on respiratory symptoms, allergy and former respiratory disease as well as exposure information will be given on a self-reported questionnaire. Changes in lung function indices, nitric oxide levels and serum inflammatory markers will be calculated. Nitric oxide will only be measured in non-smokers. We will compare cement dust exposed workers with low-level or non-exposed workers (controls).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
95
Inclusion Criteria
  • Employees from a Norwegian cement production plant
Exclusion Criteria
  • Exhaled nitric oxide measurements: smokers
  • Substantial previous work in quarry or as a miner

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Lung Function Measurements During One Work Shift (6-8h)baseline and 6-8h

Changes in lung function measurements during one work shift (6-8h), spirometry and gass diffusion capacity

Secondary Outcome Measures
NameTimeMethod
Changes in FeNO Measurements During One Shift (6-8h)baseline and 6-8h
Changes in Serum/Plasma Inflammatory Markers During One Shift (6-8h)Baseline and 6-8h
Changes in Serum/Plasma Inflammatory Markers Between Baseline and 32 h0-32h
Changes in FeNO Measurements Between Baseline (0h) and 32 h0-32h

Trial Locations

Locations (1)

Sykehuset Telemark HF

🇳🇴

Skien, Norway

© Copyright 2025. All Rights Reserved by MedPath